Antonio
Domínguez Meijide
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (12)
2024
-
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission
npj Parkinson's Disease, Vol. 10, Núm. 1
2021
-
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
Frontiers in Aging Neuroscience, Vol. 13
-
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Neurobiology of Disease, Vol. 151
2020
-
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Scientific Reports, Vol. 10, Núm. 1
2018
-
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models
Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7297-7316
2017
-
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures
Brain, Behavior, and Immunity, Vol. 62, pp. 277-290
2015
-
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinsons Disease
Neuroscientist, Vol. 21, Núm. 6, pp. 616-629
2014
-
Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β
Experimental Neurology, Vol. 261, pp. 720-732
-
Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA
Neuropharmacology, Vol. 76, Núm. PART A, pp. 156-168
2013
-
Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells
Experimental Neurology, Vol. 250, pp. 384-396
-
Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease
Movement Disorders, Vol. 28, Núm. 10, pp. 1337-1342
2012
-
Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
Neurobiology of Disease, Vol. 47, Núm. 2, pp. 268-279